TSNF - ETF AI Analysis
Top Page
Truth Social American Next Frontiers ETF (TSNF)
Rating:62Neutral
Price Target:―
Positive Factors
Strong Year-to-Date Performance
The ETF has delivered strong gains so far this year, indicating positive momentum for investors who have held it over that period.
Leading Growth-Oriented Holdings
Several top positions, including well-known technology and health care names, have shown strong performance, helping drive the fund’s overall returns.
Broad Sector Diversification Within the U.S.
The fund spreads its investments across many sectors such as technology, health care, industrials, and financials, which helps reduce the impact if any single industry struggles.
Negative Factors
High Expense Ratio
The ETF charges relatively high annual fees compared with many broad market funds, which can eat into long-term returns.
Very Heavy U.S. Concentration
Almost all of the fund’s holdings are in U.S. companies, offering little geographic diversification if the U.S. market faces a downturn.
Recent Short-Term Weakness
The ETF has shown weak performance over the past month and includes some lagging holdings, which may signal higher short-term volatility.
TSNF vs. SPDR S&P 500 ETF (SPY)
AUM8.41M
RegionNorth America
Expense Ratio0.65%
Beta1.91
IssuerTruth Social
Inception DateDec 30, 2025
Dividend YieldN/A
Asset ClassEquity
Index TrackedTruth Social Yorkville American Next Frontiers Index - USD - Benchmark TR Gross
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume1,135
30 Day Avg. Volume3,038
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
41.63Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering147
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TSNF Summary
TSNF, the Truth Social American Next Frontiers ETF, follows the Truth Social Yorkville American Next Frontiers Index and focuses on U.S. companies leading new technology and industrial innovation. It spreads investments across areas like tech, health care, and industrials, with well-known names such as Advanced Micro Devices (AMD) and Applied Materials among its holdings. Investors might consider TSNF if they want growth potential from companies driving future breakthroughs, while still getting diversification across several sectors. A key risk is that it is heavily tilted toward innovative and tech-related businesses, so its value can rise and fall sharply with changes in those sectors and the broader market.
How much will it cost me?This ETF has an expense ratio of 0.65%, which means you’ll pay about $6.50 per year for every $1,000 you invest. That’s higher than the average ETF because it follows a specialized, thematic index rather than a broad, plain-vanilla market index.
What would affect this ETF?This ETF could benefit if U.S. technology and innovation-focused companies, especially in areas like space, defense, and semiconductors, continue to grow and if a strong U.S. economy and supportive government spending on tech and defense boost its top holdings. On the other hand, it could be hurt by rising interest rates that pressure growth and tech stocks, tighter regulations or shifts in government priorities affecting defense and space industries, or if its exclusion of companies with DEI policies limits its opportunity set compared with broader U.S. market funds.
TSNF Top 10 Holdings
TSNF is leaning hard into U.S. innovation, with a tech-and-healthcare core that sets the tone for performance. On the upside, names like UiPath and IQVIA are helping pull the fund forward with rising momentum around AI and data-driven services, while Hinge Health and Natera add extra spark from fast-growing digital and precision health themes. Charles River Labs and Avantor, however, look more mixed, with operational and valuation worries acting like sandbags on returns. Overall, it’s a U.S.-only, innovation-heavy portfolio with a clear tilt toward software and life sciences leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| NIQ Global Intelligence PLC | 1.48% | $125.35K | $5.35B | 7.13% | 54 Neutral | |
| Appian | 1.08% | $91.54K | $2.67B | 28.48% | 58 Neutral | |
| Charles River Labs | 1.06% | $89.32K | $13.91B | 82.40% | 60 Neutral | |
| Natera | 1.02% | $86.47K | $46.82B | 100.50% | 73 Outperform | |
| UiPath | 0.99% | $83.93K | $8.25B | 46.73% | 72 Outperform | |
| Avantor | 0.98% | $82.69K | $9.64B | 8.97% | 48 Neutral | |
| Elastic | 0.98% | $82.36K | $8.93B | 7.34% | 65 Neutral | |
| Hinge Health, Inc. Class A | 0.97% | $81.47K | $6.91B | 53.59% | 70 Outperform | |
| Bio-Techne | 0.94% | $79.00K | $11.32B | 26.68% | 64 Neutral | |
| IQVIA Holdings | 0.93% | $78.77K | $42.15B | 35.92% | 73 Outperform |
TSNF Technical Analysis
Positive
―
Price Trends
30.98
Positive
30.14
Positive
Market Momentum
0.33
Negative
54.87
Neutral
15.52
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TSNF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 30.70, equal to the 50-day MA of 30.98, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.33 indicates Negative momentum. The RSI at 54.87 is Neutral, neither overbought nor oversold. The STOCH value of 15.52 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TSNF.
TSNF Peer Comparison
Comparison Results
Performance Comparison
TSNF
Truth Social American Next Frontiers ETF
31.52
6.87
27.87%
MILN
Global X Millennial Consumer ETF
―
―
―
RBLD
First Trust Alerian US NextGen Infrastructure ETF
―
―
―
CCSO
Carbon Collective Climate Solutions U.S. Equity ETF
―
―
―
GK
AdvisorShares Gerber Kawasaki ETF
―
―
―
JXX
Janus Henderson Transformational Growth ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents